Endonovo Therapeutics Inc (ENDV)

[Seaheck]

Taken from an article earlier this year.
Interesting



More than ever in recent years, big pharma companies have the firepower necessary to do deals to build out sales and pipelines, says Forman, at Ernst & Young.
He puts the figure at $600 billion. That amount could increase by at least another $100 billion if U.S. companies are allowed to repatriate earnings at a favorable tax rate, a plan politicians in Washington, D.C. are considering.

The biggest buyout cash on hand war chests were at:
Johnson & Johnson ($42 billion); Amgen ($38 billion);
Gilead ($32 billion);
Allergan ($27 billion);
Merck ($25 billion);
Pfizer ($24 billion); and
Novartis ($23 billion).


They're just waiting on us to start FDA trials. ;)